Science
Column: Eli Lilly is slashing insulin prices, but hold your applause
Eli Lilly & Co. performed the altruism card like a champ on Mar. 1, when it introduced steep worth cuts on its insulin merchandise of as a lot as 70%.
The massive drug firm stated its motion was all about serving to diabetes sufferers, its purpose being to “assist Individuals who might have problem navigating a posh healthcare system which will preserve them from getting reasonably priced insulin.”
In line with Lilly Chairman and Chief Govt David Ricks, America’s healthcare system “nonetheless doesn’t present reasonably priced insulin for everybody, and that should change.”
Lilly goes to financial institution lots of goodwill for this, with out taking essentially a giant hit to their backside line.
— Andrew Mulcahy, Rand Company
Lilly basked in public reward after the announcement. President Biden noticed that Lilly’s cuts would power its two principal opponents, Novo Nordisk and Sanofi, to observe swimsuit.
If you happen to’re inclined to assume higher of Lilly for taking this dramatic step, right here’s our recommendation: Maintain your applause.
The reality is that Lilly’s worth cuts received’t price it a skinny dime in income; it might even gather larger income. Wall Avenue acknowledged that instantaneously: The value of Lilly shares rose on the day of the announcement and has continued to maneuver larger ever since, gaining practically 6% by Thursday’s buying and selling.
Furthermore, the value rollback nonetheless doesn’t carry Lilly insulin again to the place it must be on an inflation-adjusted foundation in contrast with the value of its key product, Humalog, upon its launch in 1996.
Again then, Humalog price $21 per vial, which might be about $40 in at the moment’s cash; the rollback will scale back the value of a vial from $274.70 to $66.40, in response to calculations by the Washington consulting agency Veda Companions. So it’s nonetheless larger by two-thirds than it must be, accounting for inflation.
One other issue driving Lilly’s announcement is the extraordinary public scrutiny on insulin’s inflated worth. The Inflation Discount Act handed final August together with a provision capping the out-of-pocket price of insulin for Medicare prescription drug enrollees at $35 a month. That profit has been extensively and loudly touted by President Biden as proof of his dedication to pro-consumer policy-making.
Consistent with that laws, one ingredient of Lilly’s price-cut announcement is a cap of $35 per 30 days on out-of-pocket expenses for insured prospects. As I’ve reported earlier than, these patient-assistance applications solely camouflage for customers the true prices of their prescriptions — insurers nonetheless pay the drugmakers’ excessive costs, which find yourself in larger premiums for everybody.
“Lilly goes to financial institution lots of goodwill for this, with out taking essentially a giant hit to their backside line,” says Andrew Mulcahy, senior researcher at Rand Corp. and lead writer of a 2020 Rand comparability of insulin costs within the U.S. and different nations.
That evaluation confirmed that U.S. insulin costs have been approach out of line with the remainder of the world: For instance, a benchmark unit price (in U.S. {dollars}) $6.94 in Australia, $12 in Canada and $7.52 in Britain —however practically $100 within the U.S. Even when Lilly’s worth cuts are adopted by its opponents, “U.S. costs are nonetheless larger than costs within the different nations,” Mulcahy instructed me, although by two to a few instances reasonably than by 10 instances.
Insulin’s excessive record worth has fueled efforts to create various sources. California Gov. Gavin Newsom final yr introduced a $100-million program to fabricate a state-branded low-cost insulin, probably by contracting with a generics agency; an announcement of particulars may come inside days. An identical effort is underway in Michigan.
Lilly’s worth cuts received’t do something to deal with the elemental dysfunction of America’s drug-pricing system, which bristles with rent-seeking entities — not simply drug producers, however pharmacy profit managers, or PBMs, middlemen who provide to barter decrease costs on behalf of well being insurers by extracting rebates however preserve a share of the purported financial savings for themselves.
Drugmakers and PBMs level their fingers at each other when excessive drug costs are challenged in lawsuits or congressional hearings. However there’s no query that the system creates incentives for top producer costs, as a result of these are obligatory to supply the headroom for rebates.
Certainly, in 2021 a Senate committee reported that Lilly executives have been reluctant to cut back costs on diabetes medication as a result of they feared PBMs would object: The lowered costs would cut back the charges the PBMs may cost their well being plan shoppers and scale back their capability to satisfy the rebate ensures that they had promised the shoppers.
The connection between drugmakers and PBMs is the difficulty in a lawsuit filed in Los Angeles state court docket by California Atty. Gen. Rob Bonta in January.
The lawsuit alleges that the three producers conspired with the three dominant PBMs, CVS Caremark, Categorical Scripts and OptumRx, to “artificially inflate” insulin costs nicely past the conventional inflation fee. Not one of the defendants has but responded to the allegations in court docket.
Because it occurs, diabetics aren’t even among the many drug customers most victimized by excessive costs within the U.S. That’s as a result of having three competing producers for what is basically a commodity drug results in massive rebates that stream by to insured sufferers a minimum of to some extent.
Rebates from record costs on insulin have averaged 70% to 80%, Mulcahy and his Rand colleagues reported in 2021. That’s not the case for most cancers medication, which may carry record costs of a whole bunch of 1000’s of {dollars} however have a tendency to not be rebated, or “disease- modifying anti-rheumatic medication” used to deal with autoimmune circumstances reminiscent of lupus, a number of sclerosis and Crohn’s illness, for which about one-third of record costs are rebated.
“Oncology is the clearest instance of medicine the place the reductions from record worth are slim to none,” Mulcahy says. That’s as a result of the motion of those medication could also be particularly focused, making it troublesome to shift a affected person from one drug to a different in quest of a cheaper price.
Almost 40 million Individuals endure from diabetes, a illness through which the physique both can’t produce insulin, the hormone wanted to manage blood sugar ranges, or can’t effectively use insulin. Some 7 million of them require every day injections of insulin.
Of these, in response to a research by Yale researchers printed final yr, 14% face “catastrophic” spending on insulin, outlined as 40% of their earnings past what they spend on meals and housing. Almost half have reported rationing their insulin provide due to its price. That’s a life-threatening technique.
They’re the victims of an infinite run-up in drugmakers’ insulin costs over the past 30 to 40 years. These costs fall into two classes: The record costs, which within the U.S. can at the moment run to greater than $200 per vial, and the out-of-pocket worth.
Every vial accommodates 1,000 doses, and the typical affected person can use two to 4 vials a month.
Few sufferers persistently pay the record worth, nevertheless. Most are charged solely a co-pay by their well being plan and even obtain insulin at no cost by Medicaid.
The excessive record worth principally harms sufferers who’ve to purchase insulin instantly, usually as a result of they’re uninsured or have high-deductible well being plans that don’t cowl all the prices. However even sufferers with good insurance coverage aren’t completely protected against the record worth, says Shaina Kasper, a diabetes sufferer who’s USA coverage supervisor for T1International, a world advocacy group for diabetics.
“Generally even folks with insurance coverage have to purchase it out of pocket,” she says. “You break a vial once you’re away on trip. You run out as a result of one thing occurs. A few weeks in the past, my canine sitter put a cargo that got here into the freezer, and all of it died. Having an possibility of with the ability to get a extra reasonably priced insulin goes to avoid wasting lives.”
Insulin has change into the “poster baby for runaway incentives for larger record costs,” as Mulcahy places it, for a number of causes.
These embrace the sheer scale of the run-up in costs, the huge markup over what it prices to supply — as little as $6 a vial — and the loopholes that insulin makers have exploited to protect their advertising rights for a product for which the patents would usually have expired a long time in the past.
One widespread approach is for producers to carry out new formulations or gadgets they declare signify vital medical enhancements. These enhancements are sometimes extra modest than the producers say, or is probably not appropriate for all customers.
Nonetheless, observes Robin Feldman, an skilled on pharmaceutical regulation on the College of California School of the Legislation, the modifications enable drugmakers to increase their advertising rights.
Sanofi, for instance, has filed 74 patent functions for its Lantus long-acting insulin drug, Feldman studies in an upcoming journal article; most have been filed after the drug got here available on the market in 2000 however have allowed Sanofi to increase its advertising rights by 2031.
Coming again to Lilly’s initiative, among the many firm’s incentives to announce its insulin worth cuts now could be Medicaid guidelines kicking in subsequent yr that penalize drugmakers for elevating costs quicker than inflation. The brand new guidelines may end in as a lot as $430 million in expenses to Lilly, by Veda’s estimates.
Due to the peculiarities of Medicaid pricing, Lilly’s reductions may end in its amassing greater than $85 million in new Medicaid revenues. Put these two elements collectively, and Lilly’s worth cuts will produce about $517 million in beneficial properties.
“Corporations act in their very own pursuits,” Feldman says. “This worth discount is not any exception. The corporate is managing to do nicely by doing good.”
Science
April Space Events: Artemis Astronauts, a Journey to Jupiter and More
If you happen to’re searching for house information in April, you received’t have to attend lengthy.
On Monday, NASA will introduce the 4 astronauts who will journey on the Artemis II mission. The Artemis program — a successor to the Apollo missions of the Sixties and ’70s — goals to return Individuals to the moon later within the decade. Artemis II will ship three American astronauts and one Canadian on a 10-day journey across the moon and again to Earth, launching as quickly as 2024.
The announcement of the mission’s crew will happen at 11 a.m. Japanese time on April 3. They would be the first people to fly past low-Earth orbit and towards the moon because the Apollo 17 mission concluded in 1972.
In the course of the month, a serious European Area Company mission will ship a spacecraft on an extended journey towards Jupiter, the photo voltaic system’s largest planet. The spacecraft, the Jupiter Icy Moons Explorer or JUICE, will concentrate on learning a number of of the gasoline large’s moons: oceanic Europa, large Ganymede and quirky Callisto.
The mission is scheduled to carry off from Europe’s spaceport in French Guiana on April 13; it would attain the Jovian system in 2031, spend 4 years performing numerous flybys and conclude with an orbit of Ganymede.
Close to the tip of April, a moon touchdown could happen. Ispace, a personal Japanese firm, launched its M1 robotic lander in December, carrying cargo constructed by the house companies of Japan and the United Arab Emirates. Touchdown on the moon is perilous, and makes an attempt by India and an Israeli nonprofit resulted in crashes in 2019. If Ispace succeeds in touching down on the moon’s floor in a single piece, it will likely be the primary personal lunar mission to take action.
The spacecraft reached lunar orbit on March 21 and the corporate has but to announce the date of its touchdown try.
Skygazers on Earth could have an opportunity to see one of many first main meteor showers of 2023 in April. The Lyrids meteor bathe turns into energetic on April 15, and reaches peak exercise on the evening of April 22 into the morning of April 23. With the moon removed from full that evening, these with clear, darkish skies have a shot at seeing fireballs streaking via the heavens.
There can even be a complete photo voltaic eclipse on April 20. However its path begins within the Indian Ocean, crossing over distant elements of Australia and Indonesia earlier than ending elsewhere within the Asia-Pacific, so it received’t be seen within the Western Hemisphere. You’ll have to attend for October, when an annular eclipse will cross from the American West into South America.
Some vital house occasions initially anticipated in April had been lately postponed. The long-delayed first flight of Boeing’s Starliner capsule carrying astronauts to the Worldwide Area Station has been moved to July. Boeing wants to finish certifications that the spacecraft is able to fly, and visitors on the house station has added to the delays.
A mission to launch a Japanese house telescope, XRISM, additionally faces delays tied to a launch failure in March of Japan’s new H3 rocket, in response to Area Information.
One other launch dealing with delays is the primary orbital journey of Starship, SpaceX’s large reusable rocket. SpaceX officers had instructed a launch in March, forward of a partly profitable floor check of the rocket’s engines in February. The corporate’s founder, Elon Musk, suggested on Twitter that an April flight was doable.
Science
Health Plans No Longer Have to Cover All Preventive Care at No Cost. Here’s What to Know.
On Thursday, a federal choose in Texas struck down an important Reasonably priced Care Act coverage: the mandate that non-public well being insurers absolutely cowl preventive care companies without charge to sufferers.
The ruling took impact instantly and applies nationwide. It impacts dozens of doubtless lifesaving preventive well being care companies that the federal authorities recommends, together with medicine that stop H.I.V. transmission and screenings for adolescent despair.
Well being coverage specialists describe free preventive care as certainly one of Obamacare’s most transformative insurance policies as a result of it took away a monetary barrier to wanted look after tens of tens of millions of People. Additionally it is one of many legislation’s extra well-liked provisions, with 62 p.c of the general public just lately saying it’s “crucial” that it keep in place.
The brand new court docket ruling has already introduced the Reasonably priced Care Act again into the political fray, as Democrats shortly vowed to guard the legislation. The Biden administration plans to enchantment the ruling, organising the potential for yet one more presidential election cycle with a possible Supreme Court docket problem to Obamacare looming.
For now, despite the fact that the ruling has huge attain, most individuals aren’t prone to see their well being advantages change in a single day. Here’s what shoppers must find out about how the ruling might change medical health insurance in america.
What did the choose discover?
The Reasonably priced Care Act depends on three panels of well being care specialists to advise the federal government on what preventive companies insurers should cowl.
Decide Reed O’Connor of the Federal District Court docket for the Northern District of Texas dominated that a type of panels, america Preventive Companies Process Power, didn’t have constitutional authority to dictate what advantages well being insurers should cowl.
Decide O’Connor had dominated in 2018 that the whole Reasonably priced Care Act was unconstitutional, however the Supreme Court docket later overturned that call and upheld the legislation. On this new case, Decide O’Connor discovered that having a panel of out of doors specialists decide which preventive companies must be coated violated the Structure’s appointments clause, which says that legally vital choices should be made by people who find themselves a part of a series of authority as much as the federal authorities.
“The argument is that this can be a physique of personal specialists who serve in a volunteer capability, who will not be federal officers and will not be correctly appointed,” stated Nicholas Bagley, a professor of legislation on the College of Michigan who has adopted the Texas case carefully.
Who’s affected by the ruling?
The Reasonably priced Care Act’s preventive companies mandate probably impacts all People with personal well being protection, not simply those that get insurance coverage by way of the Obamacare marketplaces.
That’s roughly 150 million individuals, most of whom get their well being advantages by way of their jobs. The ruling doesn’t seem to have an effect on individuals with public insurance coverage corresponding to Medicare or Medicaid.
What well being advantages are at stake?
The Texas ruling implies that insurers now not have to supply free protection for any care america Preventive Companies Process Power has really useful since 2010.
In that point, the federal process power has endorsed not less than 4 new sorts of preventive care. This consists of three new sort of screenings: one for anxiousness in youngsters, one other for unhealthy drug use and a 3rd for weight achieve in pregnant ladies. It additionally features a suggestion for PrEP, a day by day tablet that’s extremely efficient at stopping the transmission of H.I.V.
The duty power has additionally up to date a lot of its older steering. For instance, it has repeatedly up to date its suggestions on coronary heart illness to endorse using statins in sure grownup populations. Underneath the Texas ruling, insurers wouldn’t need to comply with the newer steering and will as an alternative present free protection for no matter suggestions have been made in 2009 or earlier.
The ruling doesn’t have an effect on all preventive care. Insurers are nonetheless required to cowl all sorts of contraception, for instance, and all really useful vaccines (together with the Covid-19 vaccine) without charge to sufferers. They’re additionally nonetheless required to cowl mammograms, pap smears and different frequent screenings the duty power had really useful earlier than 2010, however they won’t need to comply with any of its newer steering on when these exams are applicable.
Will medical health insurance plans change instantly?
Because the ruling took impact instantly and applies nationwide, well being insurers might legally begin making use of co-payments and deductibles to the newer sorts of preventive well being care. However well being coverage specialists and insurance policy say they don’t count on many shoppers to expertise a right away change to their advantages.
That’s as a result of well being plans sometimes have insurance policies that span a full 12 months, and it’s uncommon for them to vary member advantages in the course of a contract, particularly when the court docket case remains to be ongoing. Insurers could also be reluctant to instantly take away a well-liked profit that, in some circumstances, saves them cash by stopping severe illness in a while.
Matt Eyles, the president of AHIP, the commerce group representing well being insurers, stated in a press release on Thursday that “there will likely be no fast disruption in care or protection.”
The Biden administration plans to enchantment the choice, in accordance with a court docket submitting made Friday afternoon. Consultants additionally count on the federal authorities to pursue a keep of the ruling whereas the appeals course of performs out, though the White Home has not but commented on when it would accomplish that.
A keep would put the Texas court docket’s resolution on maintain and convey the preventive care mandate again into impact till greater courts can weigh in on the case.
Mr. Bagley stated that if the Texas resolution is stayed, the case would in all probability take years to wind its option to the Supreme Court docket as a result of the problem could be much less pressing.
But when a keep shouldn’t be issued, the case might transfer shortly and probably attain the Supreme Court docket earlier than the 2024 election.
“It might set off a little bit of a race to the Supreme Court docket,” he stated.
In a Thursday briefing, the White Home press secretary, Karine Jean-Pierre, stated the Biden administration “will proceed to struggle to enhance well being care and make it extra reasonably priced for hard-working households, even within the face of assaults from particular pursuits.”
Democrats have just lately discovered political success in defending the Reasonably priced Care Act, notably since Republican efforts to repeal the legislation in 2017 failed. Obamacare has steadily develop into extra well-liked, and this new lawsuit might make it a extra outstanding concern within the 2024 presidential marketing campaign.
Republicans have been principally silent on the ruling, an indication that dismantling the Reasonably priced Care Act might have develop into a dropping concern for the social gathering. Prime congressional Democrats have been fast to defend the Reasonably priced Care Act. Senator Patty Murray of Washington stated in a Thursday assertion, “The Reasonably priced Care Act’s protections have repeatedly been upheld within the face of nonstop assaults,” including, “I’m not new to this struggle, and I’ve no intention of backing down now.”
Science
Medicare Delays a Full Crackdown on Private Health Plans
The Biden administration on Friday finalized new guidelines meant to chop down on widespread overbilling by non-public Medicare Benefit insurance coverage, however softened the method after intense lobbying by the business.
Regulators are nonetheless shifting ahead with guidelines that can decrease funds to insurers by billions of {dollars} a yr. However they are going to section within the adjustments over three years, moderately than abruptly, and that can reduce the fast results.
Within the brief time period, non-public well being plans will nonetheless have the ability to obtain funds that Medicare officers don’t think about applicable. The system will ultimately eradicate further funds the insurers obtain for protecting sufferers underneath 2,000 diagnoses, together with 75 that seem like the topic of widespread manipulation.
However the prolonged timetable might additionally mitigate issues raised by well being plans, medical doctors and others that the broad coverage change may end in unintended penalties, reminiscent of will increase in premiums or reductions in advantages for Medicare Benefit beneficiaries.
Within the two months because the proposal turned public, insurers and their allies had mounted an costly, loud lobbying marketing campaign, using tv commercials, pressuring lawmakers on Capitol Hill and enlisting hundreds to file feedback opposing the company’s proposal.
The nation’s high Medicare official acknowledged on Friday that the business’s outcry influenced the form of the brand new guidelines.
“We have been actually snug in our insurance policies, however we all the time wish to hear what stakeholders must say,” stated Chiquita Brooks-LaSure, the administrator of the Facilities for Medicare and Medicaid Providers. She stated want for a slower coverage shift was “one thing that we actually heard come by from our feedback, and we wished to be responsive.”
The brand new fee formulation is a response to mounting proof over greater than a decade that non-public insurers have been exploiting a formulation to extract overpayments from the federal authorities. Plans are eligible for further funds for sufferers whose sicknesses might be costlier to cowl, which has inspired many to go to nice lengths to diagnose their clients with as many well being circumstances as doable. Insurers are amassing tens of billions of {dollars} in further funds a yr, in accordance with varied estimates.
Almost each giant insurer in this system has settled or is going through a federal fraud lawsuit for such conduct. Proof of the overpayments has been documented by tutorial research, authorities watchdog reviews and plan audits.
Regardless of the excesses and issues that Medicare Benefit too usually denies wanted care, about half of all Medicare beneficiaries are actually enrolled within the non-public plans, which obtain authorities outlays of greater than $400 billion a yr. It stays in style with customers, who usually get pleasure from decrease premiums and advantages — like imaginative and prescient and dental companies — that the fundamental authorities Medicare plan doesn’t provide.
This system has additionally turn out to be worthwhile for the most important insurance coverage corporations. Current analysis from the Kaiser Household Basis discovered that insurers make about double the gross margins with Medicare plans that they make with their different strains of enterprise. Humana not too long ago introduced that it might cease providing business insurance coverage to give attention to Medicare, which serves older and disabled People, and Medicaid, which principally serves low-income populations.
The brand new rule will ultimately eradicate the additional funds for a lot of diagnoses that Medicare Benefit plans have been generally reporting however that Medicare knowledge didn’t present have been related to extra medical care. These analysis codes included just a few that non-public plans had particularly focused, like diabetes “with issues” and a type of extreme malnutrition that’s usually seen in nations experiencing famine.
With the three-year phase-in, insurers will obtain funds which might be primarily based on one-third of the brand new formulation within the first yr, and two-thirds on the outdated one. Altogether, Medicare estimates that Medicare Benefit plans can be paid 3.32 % extra subsequent yr than this yr. Beneath the unique limits proposed by the administration, that enhance would have been round 1 %. Earlier adjustments within the fee mannequin have additionally taken three years.
The coverage’s opponents have argued that the change might erode advantages for the plans’ clients, and might need a disproportionate impact on poor and minority populations. The slower rollout didn’t mollify them.
“Whereas we recognize that C.M.S. moved to a phased-in method, the underlying coverage is essentially unchanged,” stated Mary Beth Donahue, the president of the Higher Medicare Alliance, an business group that spent eight figures on tv advertisements preventing the coverage. “We stay involved in regards to the unintended penalties for seniors of this risk-adjustment coverage.”
However the Alliance of Neighborhood Well being Plans, a gaggle representing nonprofit insurers, stated in an announcement that it authorised of the brand new method: “We help the risk-adjustment mannequin adjustments to give attention to delivering outcomes for customers and handle underlying incentives to aggressively doc.”
Insurers have usually challenged the company’s Medicare actions in court docket, however it’s unclear whether or not any insurers will contest this coverage.
Some advocates and consultants stated they discovered the brand new formulation too timid. The Medicare Fee Advisory Fee (MedPAC), which recommends insurance policies to Congress, wrote in a remark letter that the proposed adjustments, whereas “directionally right, are inadequate to handle the magnitude of extra Medicare spending.”
Mark Miller, a former government director at MedPAC, had urged Medicare to go even additional than its preliminary proposal. He’s now an government vp at Arnold Ventures, a coverage and advocacy group intently affiliated with a gaggle that funded tv advertisements defending the change. He described the ultimate method as a disappointment. “They’re primarily bowing to the plans,” he stated in an e-mail.
In February, just a few weeks after issuing their proposal, high well being officers within the Biden administration vigorously defended the change. In a sequence of tweets, Secretary Xavier Becerra of Well being and Human Providers characterised criticisms of the coverage as “disinformation being pushed out by high-paid business hacks and their allies.” In an interview with The New York Instances, Dr. Meena Seshamani, Medicare’s high official, stated she was dedicated to “holding the business accountable for gaming the system.”
Ms. Brooks-LaSure’s feedback Friday have been extra measured, emphasizing the views of “stakeholders” within the Medicare program. She stated she didn’t really feel that Medicare was folding to business stress.
The fee change is certainly one of a sequence of robust guidelines for this system not too long ago proposed or accomplished by the administration. One other proposal would place tighter controls on business advertising and make it more durable for plans to disclaim care to sufferers. And a rule finalized in January requires the plans to repay the federal government for a better share of overpayments uncovered by audits.
Although the Medicare Benefit program has lengthy loved robust bipartisan help on Capitol Hill, few main lawmakers have stepped ahead on this spherical to defend the plans, regardless of all of the lobbying. Republicans on committees that oversee the packages wrote letters to Medicare officers asking technical questions in regards to the change, however prevented robust criticism of the coverage. On Tuesday, 17 Home Democrats despatched Medicare officers a letter asking them to delay implementation, however not cancel it.
Invoice Cassidy of Louisiana, a doctor who’s the highest Republican on the Senate Well being, Schooling, Labor and Pensions Committee, and Senator Jeff Merkley, a Democrat from Oregon, launched laws on Tuesday that may take additional steps to forestall “unreasonable funds, coding or diagnoses.”
-
Vermont5 months ago
Button Up for winter with these weatherization tips from Efficiency Vermont
-
Midwest11 months ago
Kansas lawmaker doesn’t want to share restroom with ‘huge’ transgender colleague
-
Northeast11 months ago
Seattle convict admits he used Facebook to coerce Massachusetts girl to run away with him
-
West11 months ago
San Diego Unified School Board unanimously passes resolution in support of abortion rights
-
West11 months ago
Armed and dangerous Oregon fugitive wanted for rape, assault after prison escape: ‘Somebody very scary’
-
West11 months ago
Utah man allegedly high on meth driving 100 mph crashes, kills two 3-year-old boys, sheriff says
-
Colorado8 months ago
Colorado Rockies game no. 116 thread: Zac Gallen vs José Ureña
-
Midwest11 months ago
See it: Tesla crashes into Columbus convention center at 70 mph